
Sign up to save your podcasts
Or
In this episode, we talk to Ben Cranfield, who is undertaking a PhD In the Department of Behavioural Science and Health at UCL.
Paper: Primary care blood tests before cancer diagnosis: National Cancer Diagnosis audit data
Available at: https://doi.org/10.3399/BJGP.2022.0265
Evidence relating to the predictive value of blood tests for cancer diagnosis is growing, yet how often they are used by GPs in pre-diagnosed cancer patients is unclear. In England, two-fifths of patients subsequently diagnosed with cancer in 2018 had at least one full blood count, urea & electrolyte or liver function test. Blood test use was less likely in women, non-white and younger patients and more likely in those presenting with non-specific symptoms, with longer intervals to referral and diagnosis being associated with tested patients. This research highlights potential unmet need for interventions to reduce the risk of overuse (in populations presenting with more-specific symptoms) and underuse (in patients presenting with less-specific symptoms) of blood tests in cancer populations.
In this episode, we talk to Ben Cranfield, who is undertaking a PhD In the Department of Behavioural Science and Health at UCL.
Paper: Primary care blood tests before cancer diagnosis: National Cancer Diagnosis audit data
Available at: https://doi.org/10.3399/BJGP.2022.0265
Evidence relating to the predictive value of blood tests for cancer diagnosis is growing, yet how often they are used by GPs in pre-diagnosed cancer patients is unclear. In England, two-fifths of patients subsequently diagnosed with cancer in 2018 had at least one full blood count, urea & electrolyte or liver function test. Blood test use was less likely in women, non-white and younger patients and more likely in those presenting with non-specific symptoms, with longer intervals to referral and diagnosis being associated with tested patients. This research highlights potential unmet need for interventions to reduce the risk of overuse (in populations presenting with more-specific symptoms) and underuse (in patients presenting with less-specific symptoms) of blood tests in cancer populations.
105 Listeners
40 Listeners
72 Listeners
19 Listeners
32 Listeners
48 Listeners
14 Listeners
19 Listeners
9 Listeners
1,021 Listeners
4 Listeners
835 Listeners
1,936 Listeners
7 Listeners
194 Listeners